SPOTLIGHT -
Washington, DC-New technology that advances cataract surgery is critical to boosting the quality of life of America's senior citizens, representatives of the ophthalmic industry told congressional leaders.
WVU Medicine to expand, relocate WVU Eye Institute
(EyePod) From idea to impact: Navigating ophthalmic innovation
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410
EyePod: Modifier Gene Therapy: What is it?
Intracortical Visual Prosthesis achieves 2 years of successful testing
SalioGen Therapeutics taps development candidate for ABCA4-mediated Stargardt disease